Hongbo Shi | Immunology of Infections | Innovative Research Award

Posted on by Infectious

Innovative Research Award

Researcher: Hongbo Shi
Institution: Beijing You An Hospital, Capital Medical University

Hongbo Shi
Affiliation Beijing You An Hospital, Capital Medical University
Country China
Scopus ID 55326480500
Documents 67
Citations 2152
h-index 18
Subject Area Immunology of Infections
Event International Research Awards on Infectious Diseases

The Innovative Research Award recognizes distinguished scientific contributions that advance infectious disease research through original investigation, translational innovation, and measurable academic impact. Hongbo Shi has established a significant publication record in infection immunology, supported by consistent scholarly output, citation performance, and interdisciplinary collaboration within clinical and biomedical research.[1]

Abstract

Hongbo Shi has contributed extensively to infectious disease immunology through clinically relevant research that integrates laboratory investigation with patient-centered applications. His publication portfolio demonstrates sustained productivity, supported by 67 indexed documents, more than 2,100 citations, and an h-index of 18. Research activities primarily address immune mechanisms, host–pathogen interactions, and translational strategies for improving diagnosis and treatment. These scholarly achievements reflect continuous scientific engagement, interdisciplinary collaboration, and meaningful influence on infection-related biomedical research, making his academic profile well aligned with the objectives of the Innovative Research Award and international recognition within infectious disease sciences.[1]

Keywords

Infectious Diseases, Immunology, Host Immunity, Clinical Research, Translational Medicine, Pathogen Biology, Biomedical Innovation, Infection Control, Scientific Publications, Innovative Research Award.

Introduction

Infectious disease research requires continuous scientific innovation to improve prevention, diagnosis, and treatment. Investigators combining clinical expertise with laboratory science provide evidence supporting modern healthcare advancements. Hongbo Shi’s research reflects this multidisciplinary approach through studies addressing immunological responses and infection biology while contributing to internationally recognized scientific literature.[2]

Research Profile

The research profile demonstrates sustained scholarly productivity with 67 Scopus-indexed publications, 2,152 citations, and an h-index of 18. Affiliated with Beijing You An Hospital, Capital Medical University, Hongbo Shi focuses on immunology of infections and translational medical research that bridges fundamental discoveries with clinical healthcare applications.[1]

Research Contributions

Research contributions include investigations into immune regulation, infectious disease mechanisms, and translational therapeutic strategies. Collaborative publications have expanded scientific understanding of host responses to infection while supporting evidence-based clinical practice. These contributions strengthen ongoing biomedical research addressing emerging and persistent infectious diseases worldwide.[3]

Publications

The publication record reflects consistent academic productivity across peer-reviewed journals indexed by Scopus. Research articles emphasize immunological mechanisms, infectious disease pathology, and clinical translation. Citation performance demonstrates continued scholarly engagement, indicating that published findings have contributed meaningfully to contemporary biomedical literature and subsequent scientific investigations.[3]

Research Impact

Citation metrics and publication quality indicate significant academic influence within infectious disease research. The combination of a substantial citation count and established h-index reflects sustained recognition by the international scientific community while supporting continued advancement of infection immunology and translational medicine.[1]

Award Suitability

The Innovative Research Award recognizes measurable scientific excellence, originality, and influence within biomedical research. Hongbo Shi’s documented publication record, citation performance, institutional affiliation, and contributions to infection immunology collectively demonstrate strong alignment with evaluation criteria commonly applied to international academic recognition programs.[1]

Conclusion

Hongbo Shi’s scholarly achievements illustrate a sustained commitment to advancing infectious disease research through rigorous investigation and collaborative scientific practice. His academic profile demonstrates research excellence, measurable impact, and continued contributions that support innovation in immunology, translational medicine, and evidence-based healthcare for infectious diseases.[1]

External Links

References

  1. Elsevier. (n.d.). Scopus author details: Hongbo Shi, Author ID 55326480500. Scopus.
    https://www.scopus.com/pages/authors/55326480500
  2. Lai, J., Hu, D., Yan, M., Zhang, H., & Bai, L. (n.d.). A novel off-liver sinusoidal progenitor cells in supporting transplantable bioliver engineering.
    https://www.sciencedirect.com/science/article/abs/pii/S2772950825001852
  3. Xu, L., Jiang, Y., Zheng, X., & Shi, H. (n.d.). Immuno-cell metabolic changes in HIV-1 infection.
    https://www.researchgate.net/publication/389782415

Shayan Zamani | Antiviral Therapies and Resistance Mechanisms | Best Researcher Award

Posted on by Infectious

Dr. Shayan Zamani | Antiviral Therapies and Resistance Mechanisms | Best Researcher Award

MD | Tehran University of Medical Sciences | Iran

Dr. Shayan Zamani is a dedicated Clinical Research Fellow at the Center for Research and Training in Skin Diseases and Leprosy, Tehran University of Medical Sciences, where he has established a strong foundation in dermatology, oncology, and hematopoietic stem cell transplantation. He earned his Doctor of Medicine (MD) with a focus on dermatologic research and clinical therapeutics, combining his medical expertise with evidence-based research in complex dermatological and oncologic disorders. Throughout his career, Dr. Zamani has contributed to multidisciplinary research collaborations exploring topics such as graft-versus-host disease (GVHD), drug-resistant fungal infections, cutaneous complications in oncology patients, and innovative nanoliposomal treatments for fungal and inflammatory skin diseases. His professional experience spans both clinical and laboratory environments, where he integrates translational methodologies to improve diagnostic precision and patient outcomes. His research interests center on dermatologic oncology, infectious skin diseases, immunodermatology, and regenerative therapies, supported by his skills in clinical trial design, biomarker analysis, molecular diagnostics, and data-driven evaluation of treatment efficacy. Dr. Zamani has authored several peer-reviewed publications in reputable journals such as JDDG: Journal der Deutschen Dermatologischen Gesellschaft, Frontiers in Oncology, and Dermatologic Therapy, contributing valuable insights into skin disease pathophysiology and treatment optimization. His work has earned him recognition for academic excellence and commitment to advancing medical science. Dr. Zamani has actively participated in research collaborations and conferences, reflecting strong leadership and dedication to clinical innovation. With a growing publication record and a clear focus on improving therapeutic outcomes, he continues to strengthen his role in advancing dermatologic and oncologic research globally. His academic impact is demonstrated by 19 citations , 11 publications, and an h-index of 3.

Profiles : Google Scholar | Scopus | ORCID

Featured Publications

1. Tamimi, P., Fattahi, M., Ghaderi, A., Firooz, A., Shirvani, F., Alkhen, A., & Zamani, S. (2024). Terbinafin‐resistente Trichophyton indotineae mit F397L/L393S‐ oder F397L/L393F‐Mutation bei Patienten mit Tinea incognita unter Glukokortikosteroiden. JDDG: Journal der Deutschen Dermatologischen Gesellschaft, 22(7), 922–935.

2. Samadi, A., Ayatollahi, A., Kashani, M. N., Zamani, S., & Firooz, A. (2023). Efficacy and tolerability assessment of a polynucleotide‐based gel for improvement of pattern hair loss: A polynucleotide‐based gel for improvement of pattern hair loss. [Journal name not specified].

3. Mehdizadeh, M., Tehrani, H. A., Rezvani, H., Zamani, S., Salari, S., & Hajifathali, A. (2023). Maintenance therapy with Everolimus in patients with refractory or relapsing Hodgkin lymphoma after autologous stem cell transplantation. Blood Cell Therapy, 6(3), 87–93.

4. Zamani, S., Azhdari, H., & Mehdizadeh, M. (2023). Efficacy and safety profile of Everolimus as a maintenance therapy for primary refractory/relapsing Hodgkin lymphoma following autologous hematopoietic stem cell transplantation. HemaSphere, 7(S3), e9236902.

5. Zamani, S., Mehdizadeh, M., & Salem, A. (2023). Allogeneic stem cell transplantation outcomes in Hodgkin lymphoma: A prognostic study of 30 patients with relapsed and refractory Hodgkin lymphoma. HemaSphere, 7(S3), e621289b.

 

Hassan Babamohamadi | Viral Infections | Best Researcher Award

Posted on by Infectious

Prof. Dr. Hassan Babamohamadi | Viral Infections | Best Researcher Award

Clinical Trial | Semnan University of Medical Sciences | Iran

Dr. Hassan Babamohamadi is a distinguished Professor of Nursing at Semnan University of Medical Sciences, Iran, recognized for his extensive contributions to nursing education, clinical practice, and research. His scholarly work encompasses diverse areas, including medical education, critical thinking, spinal cord injury, hemodialysis care, pain management, chronic disease adjustment, psychometrics, and complementary medicine. He has played a key role in advancing the quality of nursing curricula through numerous comparative studies evaluating Iranian nursing programs against international standards, contributing significantly to the development of evidence-based educational frameworks. His clinical research has explored innovative interventions such as spiritual care models, acupressure, aromatherapy, rhythmic breathing, and family-based participatory programs, offering valuable insights into patient recovery, mental health, and holistic well-being. With a strong focus on both qualitative and quantitative methodologies, Dr. Babamohamadi’s studies emphasize improving patient outcomes, enhancing healthcare professionals’ competencies, and integrating ethical and spiritual dimensions into modern nursing. His publications in prestigious journals like BMC Nursing, Journal of Religion and Health, Complementary Therapies in Medicine, and Australian Critical Care highlight his commitment to interdisciplinary research and global academic collaboration. In addition to his prolific research output, he has contributed as an editorial board member and peer reviewer for several reputable journals, supporting the advancement of nursing science and evidence-based clinical practice. His leadership roles within academic administration, including serving as head of the Medical-Surgical Nursing Department and vice chancellor of education, reflect his dedication to academic excellence and institutional development. Dr. Babamohamadi’s research continues to influence the evolution of nursing education and clinical innovation, strengthening the bridge between theory and practice across health sciences. 3806 Citations, 56 Documents, 17 h-index, View h-index.

Profiles : Google Scholar | Scopus| ORCID

Featured Publications

Ong, K. L., Stafford, L. K., McLaughlin, S. A., Boyko, E. J., Vollset, S. E., Smith, A. E., … (2023). Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: A systematic analysis for the Global Burden of Disease Study 2021. The Lancet, 402(10397), 203–234.Cited by 3415

Shin, Y. H., Hwang, J., Kwon, R., Lee, S. W., Kim, M. S., … (2023). Global, regional, and national burden of allergic disorders and their risk factors in 204 countries and territories, from 1990 to 2019: A systematic analysis for the Global Burden of Disease Study. Allergy, 78(8), 2232–2254.Cited by 298

Safdarian, M., Trinka, E., Rahimi-Movaghar, V., Thomschewski, A., Aali, A., … (2023). Global, regional, and national burden of spinal cord injury, 1990–2019: A systematic analysis for the Global Burden of Disease Study 2019. The Lancet Neurology, 22(11), 1026–1047.Cited by 216

Pourteimour, S., Yaghmaei, S., & Babamohamadi, H. (2021). The relationship between mental workload and job performance among Iranian nurses providing care to COVID‐19 patients: A cross-sectional study. Journal of Nursing Management, 29(6), 1723–1732.Cited by 206

Bender, R. G., Sirota, S. B., Swetschinski, L. R., Dominguez, R. M. V., Novotney, A., … (2024). Global, regional, and national incidence and mortality burden of non-COVID-19 lower respiratory infections and aetiologies, 1990–2021: A systematic analysis from the Global Burden of Disease Study. The Lancet Infectious Diseases, 24(9), 974–1002.Cited by 203